Basket

0554659 - BTÚ 2023 RIV US eng J - Journal Article
Klánová, M. - Kazantsev, D. - Pokorná, E. - Zikmund, T. - Karolová, J. - Behounek, M. - Renesova, N. - Sovilj, Dana - Kelemen, Cristina D. - Helman, K. - Jaksa, R. - Havranek, O. - Anděra, Ladislav - Trněný, M. - Klener, P.
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.
Molecular Cancer Therapeutics. Roč. 21, č. 1 (2022), s. 89-99. ISSN 1535-7163. E-ISSN 1538-8514
R&D Projects: GA ČR(CZ) GA19-08772S; GA MZd(CZ) NU21-03-00386
Institutional support: RVO:86652036
Keywords : gene-expression * elderly-patients * bcl-2 family * venetoclax * chemotherapy
OECD category: Oncology
Impact factor: 5.7, year: 2022
Method of publishing: Open access
https://aacrjournals.org/mct/article/21/1/89/675161/Anti-apoptotic-MCL1-Protein-Represents-Critical
Permanent Link: http://hdl.handle.net/11104/0331895